TRANSCENTA HOLDING LIMITED

Press Releases Transcenta Holding Limited

Equities

6628

KYG9005B1041

Market Closed - Hong Kong S.E. Other stock markets 01:38:22 10/05/2024 pm IST			5-day change	1st Jan Change
1.89 ^HKD	0.00%		+4.42%	-47.35%

30/04	Transcenta Holding Limited Announces Board and Nomination Changes	CI
09/04	Transcenta Partners with Agilent to Develop Claudin18.2 Companion Diagnostic	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcenta Holding Limited (6628.HK) to Hold 2023 ASCO Business Update call Conference.	02/23/02	PR
Transcenta's Osemitamab Targeting Claudin18.2 Granted Orphan Drug Designation for Treatment of Pancreatic Cancer	30/23/30	AQ
Transcenta to Present Two Preclinical Studies at AACR 2023	23/23/23	AQ
Transcenta Announces First Patient Dosed in the U.S. Study of Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors	23/23/23	AQ
Transcenta Holding Limited (6628.HK) to Hold 2022 Annual Results Release Conference Call	20/23/20	PR
Transcenta Holding Limited - Results of CLDN18.2-targeting Immuno-PET Probe for Non-invasive Imaging in Gastrointestinal Tumors Published	06/23/06	AQ
Transcenta to Hold 3 Exchange Sessions on Post-SITC Business Update Call & TST003 data release and pipeline development progress update	09/22/09	PR
Transcenta to Present Two Scientific Posters at SITC 2022 Annual Meeting	14/22/14	PR
Claudin18.2, a shining star in gastric cancer, Transcenta's TST001 stands at the global forefront	28/22/28	AQ
Transcenta Holding Product pipeline progressing well	01/22/01	AQ
Transcenta Holding (06628): Product pipeline progressing well with significant competitive differentiation	01/22/01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW